Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
ICOP should move off ALAN...all the sub 30's have been popping - ICOP same float and good financial shape with new contracts - 50's at least
ICOP should move off ALAN...all the sub 30's have been popping - ICOP same float and good financial shape with new contracts - 50's at least
nice call on that one SS
SMOD - should see 50% move mid term on earnings and guidance - looks like its working on around a 10pe - way too low for sector
CCME permissible yes....the only banned word here would be y a b a d ...not a fan of wishy washy pumping that flop opinions more often than I change my underwear lol
Have a chance to listen to the CC? I have only caught the tail end of question period so far - yet to catch replay. Drex update looks damn impressive though. Just need to see initial reaction off the CC and a true 52 week break - I'll likely grab some more as I lightened load a bit pre earnings. I'll likely post a little more here on big boards as I won't be posting on the pit - welcome anyone to post.
Side note, was runnings some earnings scans tnite and found AIRT - thinly followed (and thin float) and management seems to take conservative approach, but I'm liking what I see so far there. Monster EPS - maybe 1.8 this year (1Q left), and no debt.
yeah, gone pretty crazy there - I guess lupin is trying to clean house though which I can at least appreciate - he's putting in the effort. Don't know why so much hatred/bashing towards your plays - even bucy getting in on the action today. Lion protecting against people going all in? Well chit, you never encouraged that, you always encourage people to do their own DD...? Maybe lion will get his $2 drop on CCME before it doubles exactly like APWR did...who knows...whats the point thou - prove you are right with a $2 short when all it was was temporary pressure during a run to maybe north $20? I'll be glad once this month is over as we will know damn well by the end of it what path CCME will be taking.
Thanks for stopping by - welcome to use this whenever.
ohhh, stupid non friendly paste...didn't realize it was only working for me because it was still in cache...
check:
http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Reports.MonthlyApprovalsAll
select all approvals by months (03/2010) and look for app pharm
http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.DrugDetails
Unless the context otherwise requires, references in this report to “Fresenius Kabi Pharmaceuticals,” “FKP Holdings, Inc.,” “FKP Holdings,” “the Company,” “we,” “us” and “our” refer to “Fresenius Kabi Pharmaceuticals Holding, Inc. and its subsidiaries, including our operating subsidiary APP Pharmaceuticals, Inc, or
APCVZ FDA approval link:
http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.DrugDetails
Unless the context otherwise requires, references in this report to “Fresenius Kabi Pharmaceuticals,” “FKP Holdings, Inc.,” “FKP Holdings,” “the Company,” “we,” “us” and “our” refer to “Fresenius Kabi Pharmaceuticals Holding, Inc. and its subsidiaries, including our operating subsidiary APP Pharmaceuticals, Inc, or
APCVZ FDA approval link:
http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.DrugDetails
Unless the context otherwise requires, references in this report to “Fresenius Kabi Pharmaceuticals,” “FKP Holdings, Inc.,” “FKP Holdings,” “the Company,” “we,” “us” and “our” refer to “Fresenius Kabi Pharmaceuticals Holding, Inc. and its subsidiaries, including our operating subsidiary APP Pharmaceuticals, Inc, or
Good idea - post your lion name when you first drop in if you can so we know who is who. If you'd rather hide, its kinda silly as its pretty easy to figure it out by posting style, but it is what it is and I'm fine either way.
can't even get first on my own board...how sad...lol
If other guys want to post here, that works, but obviously with this being a pay site (except for grandfathers like me..lol), posting is somewhat restricted without sinking money in. If lion goes dead though, come on over here is the point and if you are already a member, all the better :)
PSGI recurring annual revenues news equal to current market cap??? Should move much higher here 10-20c IMH given 52 week chart
EXBX bid moved up 0.013x0.014 - get some volume and that should push it in the right direction
EXBX - looking ripe for a nice 50-100% bounce here
thats in canada...questrade is no frills, no restrictions, lousy customer support - many of the penny players do use them thou
waterhouse has restricted all otc/pinks within the last 2 weeks - not just select ones. The lower level guys are cheating in our defence and leaving the permission switch on at times - their manager reviews all accounts every couple days and flips them back off (ie, restricted call-ins) - its a pile of crap and I've missed huge gains last few days with their games. I am going to either Questrade, or I have also heard royal bank has no restrictions as well so I'm looking into that as well.
yeah, tried that - TDW doesn't take the + either
anyone know the TD waterhouse symbol for axg warrants? I've tried just about everything....axg axgww axg.ws axgws axgwt axg.wt etc etc Would like to put on watch
yeah, been sifting, but figure people here would know quicker what is more ideal for us penny traders - apparently Credential Direct and Disnat are both good brokerages - couldn't find a platform with Credential thou - probably not looking right place.
Its a tough mix - need commission under $10 (to justify it), and on-line trading acceptable without huge min starting balances required..lol
Any suggestions for Canadian brokerages? TD Waterhouse finally clamped down on ALL pinks/otc so I have to go elsewhere...IB is the only one I know for sure that allows online trading of them, but its $10k to start. I THINK questrade allows, but they suck in general. ToS is very expensive commissions for otc/pink. Anything else out there for us canucks? I just want to move my cash account but probably keep my rrsp (401) at TD.....
exactly - thx for recognizing fact....I don't own shares here, the only thing that interested me was the 2010 guidance originally and the face that it keeps getting mentioned on a forum I mod. Obviously guidance is meaning squat since everything he seems to be saying doesn't seem to be coming true so far. To say you will be comfortably profitable on Dec 15 for the Q ending Dec 31 and then coming in as a loss is a joke. Even if there are new expenses with new office, why are revenues down 45%????
This one smells to me - stocks like this are run by relentless ihubbers - as you notice, you can't say anything negative or they just throw the short card at you. Thats just a crock of chit - stocks need discussion good and bad. To ignore a terrible quarter when a big investor glossy predicted a million in revenue just a few months ago is nothing but 3rd class pump crew material.
Usually I don't even bother here as its just a waste of time arguing with these guys, but I didn't see a single thing to get excited about in this PR and here goes the big rah rah...whatever!
money spent is one thing, id be concerned more about the huge % drop in revenues - that isn't logical given 'guidance' provided just weeks prior to Q end, and if you consider the hyped up investor guidance just a few months ago of $975k revenue and almost $500k net income as per:
http://bit.ly/8YehMS
I'd say just a meagre $97k in revenue and a loss of $42k would be a huge disappointment - may as well throw those 35 pages of 'research' away. Bad enough getting credibility as a pinkie without big guidance misses and questionable revenue comparisons/numbers in PR's that don't match official filings (as they went through a month ago).
Unfortunately, the #1 rule of pinkies is NEVER INVEST - they are trading platforms, and trading platforms alone. This would signal sell to me and wait and see Q1 brings, but as I don't know which 'groups' may be working this over, anything goes.
Good luck thou.
thats a tough sell in my books - hope here was based on 2010 guidance/potential, yet 15 days prior to Q4 ending they were wrong by stating:
...Expert Group is pleased to announce that we anticipate another quarter of solid net profit......
They ended up losing 42k in Q4 from a gain of 85k in q3, and revenues were down 45%??? With the growth they claim and new offices etc, there should be no good reason why Q4 was so lousy compared to Q3. This goes no where IMH on fundamentals...guess the only steam here is based on whatever pump group or promo is running them.
They have big promises for 2010, if they can't even make predictions 15 days in advance, how can they predict a year ahead?
alerted elsewhere I assume subscriber alert - 60-80c target, more with NDA
HNAB...apparently biomed alert...has great bouncer potential too
LOL - better look again big guy - you missed critical information here as to how misleading that statement was (hint, keep looking past that bit about the $.0044 earnings per share)...you know, the part you chose to exclude.
The net income for 9month period ending
Sept 2009 is $202,536. The $202,536.00 for the 9month period is actually better than what was stated in the PR released by RR on 11/5 and I quote from the PR:"The Company recorded net income of approximately $187,192.17 or $.0044 earnings per share..." The EPS is therefore $0.0046.
yeah, this part:
for the quarter ended September 30, 2009
thats a 120% misrepresentation of the real reported Sept 30 earnings of $85,034.
The big picture, these boys deceived everyone with numbers that don't even add up, let alone misrepresenting the period the numbers were over.
DRWI - earnings were beast material AH - with forward PE in the 6-10 range, this has easy double written all over it (and thats conservative IMH)
SDIX 1.58 cancer news today
SDI Collaborates with Fred Hutchinson Cancer Research Center to Discover Biomarkers for Use in Early Detection of Cancer
NEWARK, Del. & SEATTLE--(BUSINESS WIRE)--SDI (Strategic Diagnostics Inc., Nasdaq: SDIX), a provider of biotechnology-based products and services, and Fred Hutchinson Cancer Research Center (the Hutchinson Center) today jointly announced they will collaborate to discover biomarkers for use in the early detection of a variety of cancers. Initial studies will center on pancreatic cancer.
SDI will provide the Hutchinson Center with approximately 1,000 antibodies for the collaborative studies from its unique collection of cancer antigen antibodies. The antibodies, which were designed using SDI’s proprietary Genomic Antibody Technology™, will be provided to Paul Lampe, Ph.D., full member and associate program head of the Molecular Diagnostics Program at the Hutchinson Center.
The SDI cancer antigen antibodies will be printed by the Lampe laboratory onto microarray slides and tested against up to 200 characterized patient case samples and controls in a first discovery screening assay. Upon completion, the Hutchinson Center and SDI plan to jointly publish the biomarker findings of these studies. SDI will have an option for the Hutchinson Center’s commercial rights to any work that is developed during the agreement.
A biomarker is a biological molecule that can be found in body fluids such as blood or in tissues that is a sign of a normal or abnormal process, or of a condition or disease. A biomarker may also be used to see how well the body responds to a treatment for a disease or condition. It can also be called a molecular marker or a signature molecule.
“We are excited about the opportunity to explore SDI’s proprietary Genomic Antibody Technology™ through access to its Cancer Antigen Antibody Collection with the hope of identifying novel cancer biomarkers that will advance the prognostic and diagnostic potential for these challenging diseases,” Lampe said.
The Lampe laboratory investigates the control of cell growth both at the cell biological/mechanistic level and through cancer biomarker discovery. Lampe and colleagues study the cell biology that connects gap junctions and intercellular communication (GJIC) with the control of cell growth and the cell cycle and how this relationship is disrupted during carcinogenesis.
Commenting on the announcement, Mr. Fran DiNuzzo, president and CEO of SDI, said, “We are extremely pleased to be collaborating with such a world-class team of researchers. This initiative exemplifies the value of our suite of fully-integrated immuno-solution capabilities, which includes our proprietary Genomic Antibody TechnologyTM. Moreover, it is aligned with our strategic direction as an emerging contributor to the biomarker discovery and development community. It is our hope that findings from these studies progress to help facilitate early detection of the most prominent and dangerous cancers.”
hnab - spread doesn't help - would like to see that bid move
HNAB bounce trying
CYXN at 0.62 - strong so far - it should push to around 80 near term, could easily see $2+ next year
I think with those earnings, you can justify $1-2 - preferred shares have been converted, but seems pretty damn bullish looking forward. Has better numbers than most $5 stocks.
CYXN see this one - big ramp up in revenues for Q4 and seems quite bullish into next year. This should be fairly up around $2
VSYM - scanner play this went to 0.072 on 40 unit order (they are $10000 each) - they have since doubled that and added more beyond, all in the last month - this is going over 0.10 easy - over $1 million in orders for Nov/Dec alone
VSYM running off IMSC - they sell their scanner units for 10k each and have announced around 1million in orders since November - spike to 0.072 in November was on a 40 unit order - that has since been doubled along with other smaller orders.
VSYM 0.04/0.045 - starting - full body scanners
check VSYM off IMSC - they sell their scanner units for 10k each and have announced around 1million in orders since November - spike to 0.072 in November was on a 40 unit order - that has since been doubled along with other smaller orders.
check VSYM off IMSC - they sell their units for 10k each and have announced around 1million in orders since November - spike to 0.072 was on a 40 unit order - that has since been doubled along with other smaller orders.
HNAB at 0.20 - big bounce potential from this level - check chart